NBS05 - Preorder
Newborn Screening for Cystic Fibrosis, 2nd Edition
This guideline describes newborn screening laboratory tests for detecting analytes and genetic markers associated with cystic fibrosis (CF). It includes both the primary screening tests and second-tier tests performed on newborn dried blood spot specimens, as well as the screening strategies for identifying newborns at increased risk for developing CF.
This document is available for preorder only.
Members: $42.00 → $119.00Nonmembers: $140.00
Chairholder: Debra Freedenberg, MD, PhD, FFACMG
Order Code Print: NBS05Ed2
NBS05 - Preorder Additional Details
A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process.